Results 251 to 260 of about 616,436 (300)

Lipoprotein(a), High-Sensitivity C-Reactive Protein, and All-Cause Mortality in a Primary Prevention Cohort. [PDF]

JACC Adv
Chen V, Brennan D, Costa-Scharplatz M, Cho L.   +3 more
europepmc   +1 more source

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and high-sensitivity C-reactive protein in US adults: Results from NHANES 2015-2018. [PDF]

Medicine (Baltimore)
Wang H, Chen H, Li J, Peng Y.
europepmc   +1 more source

Effects of combined high-sensitivity C-reactive protein and residual cholesterol levels on new-onset diabetes: evidence from two prospective cohort studies. [PDF]

J Transl Med
Shao Y, Li Z, Wu Q, Ye L, Shi H.
europepmc   +1 more source

Linking high-sensitivity C-reactive protein and dyslipidemia among patients with type 2 diabetes mellitus. [PDF]

Bioinformation
Kurle RD, Ganesh V, Khubya D, H Chittaragi G.   +3 more
europepmc   +1 more source

High-Sensitivity C-Reactive Protein and Statin Initiation [PDF]

Angiology, 2014
The assessment of cardiovascular risk and treatment of cardiovascular diseases are major public health issues worldwide. Inflammation is now recognized as a key regulatory process that links multiple risk factors for atherosclerosis. The substantial number of patients having cardiovascular events lack commonly established risk factors.
Trpković, Andreja, Stanimirović, Julijana, Rizzo, Manfredi, Resanović, Ivana, Soskić, Sanja S., Jevremovic, Danimir, Isenović, Esma R.   +6 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians

Postgraduate Medicine, 2011
The measurement of C-reactive protein (CRP) using both standard and high-sensitivity CRP (hs-CRP) assays is becoming common in clinical practice. This article addresses the causes of CRP elevation and the use of different CRP assays in internal medicine, including cardiology, gastroenterology, rheumatology, infectious diseases, and oncology.
Elizabeth B, Windgassen, Luciana, Funtowicz, Tisha N, Lunsford, Lucinda A, Harris, Sharon L, Mulvagh   +4 more
openaire   +2 more sources

Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein

Annales de biologie clinique, 2017
C-reactive protein (CRP) is a polypeptide molecule belonging to the family of pentraxins. It has a molecular mass of 120,000 daltons and consists of five identical sub-units that contain each 206 amino acids. CRP is synthesized primarily by the liver in response to certain pro-inflammatory cytokines.
Mariame, Moutachakkir, Asma, Lamrani Hanchi, Azzedine, Baraou, Abderrahman, Boukhira, Saliha, Chellak   +4 more
openaire   +2 more sources

Physical Activity and High-Sensitivity C-Reactive Protein

Sports Medicine, 2006
Cardiovascular disease (CVD) remains one of the leading causes of death and disability in developed countries around the world despite the documented success of lifestyle and pharmacological interventions. This illustrates the multifactorial nature of atherosclerosis and the use of novel inflammatory markers as an adjunct to risk factor reduction ...
Eric P, Plaisance, Peter W, Grandjean
openaire   +2 more sources

High Sensitivity C-Reactive Protein in Clinical Practice

The American Heart Hospital Journal, 2003
As a growing number of patients with low low-density lipoprotein cholesterol levels are diagnosed with atherosclerosis, research has shifted toward markers of inflammation in an attempt to improve global cardiovascular risk prediction. These markers include cytokines, cell adhesion molecules, and acute phase reactants like high sensitivity C-reactive ...
José L, Torres, Paul M, Ridker
openaire   +2 more sources

High-sensitivity C-reactive proteinClinical importance

Current Problems in Cardiology, 2004
High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation that predicts incident myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death among healthy individuals with no history of cardiovascular disease, and recurrent events and death in patients with acute or stable coronary syndromes.
Shari S, Bassuk, Nader, Rifai, Paul M, Ridker   +2 more
openaire   +2 more sources